Factors that Predict Clinical Benefit of EGFR TKI Therapy in Patients with EGFR Wild-Type Lung Adenocarcinoma

DOI: 10.4046/trd.2018.0004

Keywords: Adenocarcinoma, Receptor, Epidermal Growth Factor, Lung Neoplasms

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text